OR WAIT null SECS
Contract service providers must step up their game to stay competitive in increasingly complex bio/pharma market.
The need for preclinical testing expertise is growing as molecular complexity increases.
A look at the newest innovations offers a deeper understanding of affinity ligands and their role in the future of downstream processing.
December 21, 2016
Pharma Tech introduced a new high-speed bottling line to its facility in Union, MO.
AGC adds second biopharma contract manufacturer with acquisition of CMC Biologics.
Novasep’s three facilities located in France and Germany are free of Form 483.
The company has manufactured double-digit number of batches on the new filling line, for use in early-stage clinical trials.
December 14, 2016
BMS changes its US geographic footprint with R&D investments and closures.
December 08, 2016
At the American Society of Hematology Annual Meeting, Novartis and Kite Pharma both released results from early-phase clinical trials with CAR-T therapies.
December 07, 2016
M&A activity, new business models, fundraising limits, offerings from small CDMOs, and combination products are driving decisions in the contract services market..
December 02, 2016
Biosimilars may be the key to CMO growth.
Recipharm and Laccure AB signed a commercial collaboration for the manufacture and delivery of Laccure’s bacterial vaginosis treatment.
Vetter’s Ravensburg data processing center received certification from a German industrial testing organization, certifying that the company’s customer and process data are protected.